
Laurus Labs Ltd Investor Relations Material
Laurus Labs Limited, a pharmaceutical company, develops, manufactures, and sells active pharmaceutical ingredients (APIs) and formulations in India. It involves in the development of antiviral APIs; generic APIs for hepatitis C and HIV Darunavir tablets; and oncology BCS class II drugs. The company also develops and commercializes single super specialty products comprising linezolid and formoterol. The company was incorporated in 2005 and is based in Hyderabad, India
Latest company events
Ticker symbol
LAURUSLABS
Country
India